Cloning in Global Perspective
The United Nations University Institute for Advanced Studies recently published a report on human cloning offering the international community two choices: either prepare for the legal and ethical issues associated with living, cloned humans, or prohibit human reproductive cloning.

The Bush administration wants to push clean-technology exports without taking meaningful measures to reduce greenhouse gas emissions at home. That’s the wrong message to send on the eve of a major global summit on climate change next week in Indonesia.
Nanotechnology offers great promise, but an incomplete understanding of the potential dangers and the lack of a unified regulatory framework threaten the potential of research. And despite the concerns of scientists, the public is not engaged with nanotech policy.
John Kanzius, a retired electrical engineer and TV and radio station owner, is developing one of the most promising new techniques to kill cancer cells.
Researchers working independently in Japan and the U.S. published papers this week announcing the creation of non-embryonic pluripotent stem cells. The method side-steps the ethical concerns over the destruction of embryos and could open the doors for federal funding of research on stem cells and the medical breakthroughs they promise.
A recent New York Times Op-Ed on brain response to political keywords has drawn criticism from the neuroscience community for its incomplete findings and its false air of scientific certainty.
DeCode Genetics, an Icelandic company, announced personal genome sequencing, available immediately for $985. But there’s quite a bit of fine print to consider as other companies join this infant industry.
In the Minor Cosmic Irony department, the same day that The New York Times reported the monkey cloning story on the front page, back in obituaries the paper reported the passing of Ira Levin, the novelist whose The Boys From Brazil became a fairly successful film.
Two dozen representatives from around the country met in Cambridge, MA last month to discuss interstate collaboration in stem cell research, highlighting the need for a systematic negotiation between states to allow collaboration and to unify the patchwork of currently existing regulations.
President Bush vetoed the Labor-HHS-Education appropriations bill, which would have increased funding for the National Institutes of Health from $29 billion to $30 billion and required open access to published NIH-funded research.